Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Dasatinib in Advanced Sarcomas

NCT00464620 is registered in ClinicalTrials.gov with Sarcoma Alliance for Research through Collaboration as lead sponsor.

NCT NCT00464620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00464620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Dasatinib in Advanced Sarcomas
Lead sponsor
Sarcoma Alliance for Research through Collaboration
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
May 31, 2017
Enrollment
366 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

chondrosarcoma, chordoma, epithelioid sarcoma, gastrointestinal stromal tumor (gist), giant cell tumor of bone, hemangiopericytoma, malignant peripheral nerve sheath tumors, rhabdomyosarcoma, sarcoma, alveolar soft part, sarcoma, ewing's